Enzon Pharmaceuticals, Inc.
ENZN
$0.04
-$0.01-13.33%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.34% | -1.49% | -4.04% | 0.48% | 0.87% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.43% | -20.00% | 89.42% | -13.06% | -17.60% |
| Total Current Assets | -2.39% | -1.72% | -3.46% | 0.39% | 0.71% |
|
|
|||||
| Total Current Assets | -2.39% | -1.72% | -3.46% | 0.39% | 0.71% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.10% | -- | -- | -94.44% | -14.04% |
| Total Assets | -2.43% | -1.63% | -3.49% | -0.23% | 0.60% |
|
|
|||||
| Total Accounts Payable | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Accrued Expenses | 8.06% | -71.82% | 228.36% | -33.66% | 71.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -65.37% | 13,566.67% | -99.77% | 21,233.33% | -70.00% |
| Total Other Current Liabilities | -65.37% | 13,566.67% | -99.77% | 21,233.33% | -70.00% |
| Total Current Liabilities | -32.75% | 44.95% | -66.98% | 283.11% | 6.83% |
|
|
|||||
| Total Current Liabilities | -32.75% | 44.95% | -66.98% | 283.11% | 6.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -32.75% | 44.95% | -66.98% | 283.11% | 6.83% |
|
|
|||||
| Common Stock & APIC | -0.74% | -0.73% | -0.73% | 0.44% | -0.73% |
| Retained Earnings | -1.15% | -1.41% | -0.75% | -0.10% | 0.36% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -313.66% | -77.88% | -35.07% | 8.91% | -9.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.22% | 1.23% | 1.25% | -3.61% | 1.22% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.22% | 1.23% | 1.25% | -3.61% | 1.22% |
|
|
|||||
| Total Common Equity | -313.66% | -77.88% | -35.07% | 8.91% | -9.11% |
| Total Preferred Equity | 1.22% | 1.23% | 1.25% | -3.61% | 1.22% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.87% | -2.20% | -1.15% | -2.88% | 0.55% |
|
|
|||||